FDA approves 2nd gene therapy targeting non-Hodgkin lymphomas
The US Food and Drug Administration has approved a second gene therapy for cancer, the first to target non-Hodgkin lymphomas.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Gene Therapy | Genetics | Health | Lymphoma